Weidong Cao

3.0k citations
76 papers · 2.5k indexed · h-index 30
Topics
14-3-3 protein interactions (11 papers)Ubiquitin and proteasome pathways (10 papers)Glioma Diagnosis and Treatment (9 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Weidong Cao

69 papers receiving 2.4k citations

Peers

Weidong Cao
Comparison fields: 5 of 129
  • Molecular Biology 1.3k
  • Biomedical Engineering 659
  • Electrochemistry 247
  • Cancer Research 246
  • Electrical and Electronic Engineering 221
Replace Dong‐Dong Li with:
Dong‐Dong Li China
Daoquan Tang China
Jin Xiang China
Fei Liao China
Fan Yang China
Peng Yu China
Yongmei Xie China
Zhujun Zhang China
Qi‐Hui Zhang China
Weidong Cao relative to Dong‐Dong Li China Dong‐Dong Li's profile →
Citations per field
00.5×2.8×
Dong‐Dong Li · 1×
Citations per year

Countries citing papers authored by Weidong Cao

Since Specialization
Citations

This map shows the geographic impact of Weidong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Cao more than expected).

Fields of papers citing papers by Weidong Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Cao. The network helps show where Weidong Cao may publish in the future.

Co-authorship network of co-authors of Weidong Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Cao. A scholar is included among the top collaborators of Weidong Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Cao. Weidong Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 80
4 10
5 65
6 45
7 20
8 16
9 39
10 27
11 115
12 30
13 24
14 17
15 1
16
Changes of monoamine neurotransmitters in hippocampal region post global brain ischemia of the rat
1
17 29
18 23
19 28
20 45

About Weidong Cao

Weidong Cao is a scholar working on Genetics, Cancer Research and Molecular Biology, having authored 76 papers that have together received 2.5k indexed citations. Recurring topics across this work include 14-3-3 protein interactions (11 papers), Ubiquitin and proteasome pathways (10 papers) and Glioma Diagnosis and Treatment (9 papers). The work is most often cited by research in Electrochemistry (247 citations), Molecular Medicine (144 citations) and Molecular Biology (1.3k citations). Weidong Cao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiang Zhang, Xiurong Yang, Erkang Wang, Xiuhua Sun, James P. Landers, Jerome P. Ferrance, J. N. Demas, Wei Zhang, Jifeng Liu and Weiping Liu. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026